MyVisionTest News Archive

Displaying news items tagged with Medicare (More tags »)
SELECT PAGE
First <<  1   >> Last

Uveitis
Jan 14, 2012
Anti–vascular endothelial growth factor (VEGF) treatment for neovascular age-related macular degeneration (AMD) is associated with increased risk of endophthalmitis, uveitis, and vitreous hemorrhage, according to a recent study. Since 2005, the advent and widespread use of anti–vascular endothelial growth factor (VEGF) drugs for the...

Full Article


Avastin
Apr 22, 2011
Avastin (bevacizumab) is the most popular pharmacological treatment for neovascular age-related macular degeneration (AMD) among Medicare fee-for-service beneficiaries in the United States. Over the past 3 years, both Avastin (bevacizumab) and Lucentis (ranibizumab) have emerged as the most common therapies for neovascular AMD as reported by...

Full Article


Medicare
Aug 22, 2008
Although Medicare has covered low-vision services performed by an ophthalmologist, optometrist, or occupational therapist since 2002, the number of service providers is limited, leaving many people without needed help. The Low Vision Demonstration Project offers some relief by expanding Medicare's coverage to include services provided by...

Full Article


SELECT PAGE
First <<  1   >> Last
Most Popular
Less - past - More